Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid

Clinical trial NCT00525616 · COMPLETED

Trial details

NCT number: NCT00525616
Sponsor: University Hospital, Rouen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bullous Pemphigoid

Start date: 2008-12-01
Primary completion: 2013-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.